Page last updated: 2024-10-22

amitriptyline and Graves Disease

amitriptyline has been researched along with Graves Disease in 1 studies

Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.

Graves Disease: A common form of hyperthyroidism with a diffuse hyperplastic GOITER. It is an autoimmune disorder that produces antibodies against the THYROID STIMULATING HORMONE RECEPTOR. These autoantibodies activate the TSH receptor, thereby stimulating the THYROID GLAND and hypersecretion of THYROID HORMONES. These autoantibodies can also affect the eyes (GRAVES OPHTHALMOPATHY) and the skin (Graves dermopathy).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Conte, N1
Gasparini, G1
Manente, P1
Valmachino, G1
Gasparoni, P1
Lo Giudice, C1
Rota, G1
Ferlin, G1

Other Studies

1 other study available for amitriptyline and Graves Disease

ArticleYear
[Study of prolactin in the blood in basal conditions and after stimulation with TRH in thyrotoxicosis after administration of reserpine or amitriptyline].
    La Clinica terapeutica, 1978, Jun-15, Volume: 85, Issue:5

    Topics: Adult; Aged; Amitriptyline; Female; Graves Disease; Humans; Hyperthyroidism; Middle Aged; Prolactin;

1978